Little Green Pharma’s Revenue and Sales Surge
Company Announcements

Little Green Pharma’s Revenue and Sales Surge

Little Green Pharma Ltd. (AU:LGP) has released an update.

Little Green Pharma Ltd. reports a solid financial performance with a 12% year-over-year revenue increase to $7.3 million and a 19% rise in cash receipts to $8.2 million. The company highlights strong sales growth in its CherryCo products and a significant uptick in oil and vaporizer sales, including an expansion into the French market. Future growth is anticipated with the development of new brands and the promising results from their psychedelic medicine clinical trials.

For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App